Your browser doesn't support javascript.
loading
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
Zeidner, Joshua F; Lin, Tara L; Vigil, Carlos E; Fine, Gil; Yair Levy, M; Nazha, Aziz; Esteve, Jordi; Lee, Daniel J; Yee, Karen; Dalovisio, Andrew; Wang, Eunice S; Bergua Burgues, Juan M; Schriber, Jeffrey; Litzow, Mark R; Frankfurt, Olga; Castillo, Teresa Bernal Del; Bhatt, Vijaya Raj; Bhatnagar, Bhavana; Mehta, Priyanka; Dillon, Richard; Vicente, Maria Vidriales; Anthony, Stephen; Bearss, David; Montesinos, Pau; Douglas Smith, B.
Afiliação
  • Zeidner JF; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. Joshua_Zeidner@med.unc.edu.
  • Lin TL; University of Kansas Medical Center, Kansas City, KS, USA.
  • Vigil CE; University of Iowa, Iowa City, IA, USA.
  • Fine G; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Yair Levy M; Sumitomo Dainippon Pharma Oncology, Lehi, UT, USA.
  • Nazha A; Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA.
  • Esteve J; Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
  • Lee DJ; Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Yee K; Columbia University Irving Medical Center, New York, NY, USA.
  • Dalovisio A; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Wang ES; Ochsner Medical Center, New Orleans, LA, USA.
  • Bergua Burgues JM; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Schriber J; Hospital San Pedro de Alacantra, Caceres, Spain.
  • Litzow MR; Cancer Treatment Centers of America, Phoenix, AZ, USA.
  • Frankfurt O; Mayo Clinic, Rochester, MN, USA.
  • Castillo TBD; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Bhatt VR; Hospital Universitario Central de Asturias, Asturias, Spain.
  • Bhatnagar B; Fred and Pamela Buffet Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.
  • Mehta P; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Dillon R; University Hospitals Bristol, Bristol, UK.
  • Vicente MV; Department of Medical and Molecular Genetics, King's College, London, UK.
  • Anthony S; Hospital Clinico Universitario de Salamanca, Salamanca, Spain.
  • Bearss D; Sumitomo Dainippon Pharma Oncology, Lehi, UT, USA.
  • Montesinos P; Sumitomo Dainippon Pharma Oncology, Lehi, UT, USA.
  • Douglas Smith B; University of Utah, Salt Lake City, UT, USA.
Blood Cancer J ; 11(10): 175, 2021 10 30.
Article em En | MEDLINE | ID: mdl-34718324
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Proteína de Sequência 1 de Leucemia de Células Mieloides Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Proteína de Sequência 1 de Leucemia de Células Mieloides Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article